COVID-2019 vaccine - Shenzhen Genius
Latest Information Update: 31 Oct 2021
At a glance
- Originator Shenzhen Genius Biotech
- Class COVID-19 vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 05 Oct 2020 Shenzhen Genius Biotech and National Institute for Viral Disease Control and Prevention entered into a technology transfer agreement for development of COVID-2019 vaccine
- 05 Oct 2020 Shenzhen Genius Biotech files for global patent protection for COVID-2019 vaccine
- 05 Oct 2020 Preclinical trials in COVID-2019 infections in China (unspecified route)